Endovascular recanalisation with drug coated balloon for chronic symptomatic middle cerebral artery total occlusion

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The optimal treatment for patients with chronic symptomatic middle cerebral artery (MCA) total occlusion is not well established. In addition to medical therapy, vessel recanalisation with stenting has shown much promise, especially for patients with recurrent ischemic symptoms. Nevertheless, the incidence of symptomatic in-stent restenosis (ISR) is high, and is associated with an unfavorable prognosis. Drug coated balloons (DCBs) have been proven to be effective in treating and preventing ISR. However, the feasibility of DCBs for de novo intracranial atherothrombotic stenosis has not been previously described, especially for total occlusion lesions. Here we reported a patient with chronic left MCA total occlusion successfully treated with DCBs, with a good outcome at the 1 year follow-up. More studies are warranted to further compare the efficacy of DCBs and stentings for intracranial revascularisation.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhang, J., Zhang, X., Zhang, J. P., & Han, J. (2018). Endovascular recanalisation with drug coated balloon for chronic symptomatic middle cerebral artery total occlusion. BMJ Case Reports, 2018. https://doi.org/10.1136/bcr-2017-013693

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free